位置:首页 > 蛋白库 > CSEN_HUMAN
CSEN_HUMAN
ID   CSEN_HUMAN              Reviewed;         256 AA.
AC   Q9Y2W7; H7BY46; Q3YAC3; Q3YAC4; Q53TJ5; Q96T40; Q9UJ84; Q9UJ85;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   03-AUG-2022, entry version 193.
DE   RecName: Full=Calsenilin;
DE   AltName: Full=A-type potassium channel modulatory protein 3;
DE   AltName: Full=DRE-antagonist modulator;
DE            Short=DREAM;
DE   AltName: Full=Kv channel-interacting protein 3;
DE            Short=KChIP3;
GN   Name=KCNIP3; Synonyms=CSEN, DREAM, KCHIP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN PRESENILIN
RP   REGULATION.
RX   PubMed=9771752; DOI=10.1038/2673;
RA   Buxbaum J.D., Choi E.K., Luo Y., Lilliehook C., Crowley A.C., Merriam D.E.,
RA   Wasco W.;
RT   "Calsenilin: a calcium-binding protein that interacts with the presenilins
RT   and regulates the levels of a presenilin fragment.";
RL   Nat. Med. 4:1177-1181(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN TRANSCRIPTION
RP   REGULATION.
RC   TISSUE=Caudate nucleus;
RX   PubMed=10078534; DOI=10.1038/18044;
RA   Carrion A.M., Link W.A., Ledo F., Mellstrom B., Naranjo J.R.;
RT   "DREAM is a Ca2+-regulated transcriptional repressor.";
RL   Nature 398:80-84(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN POTASSIUM
RP   TRANSPORT.
RX   PubMed=10676964; DOI=10.1038/35000592;
RA   An W.F., Bowlby M.R., Betty M., Cao J., Ling H.-P., Mendoza G.,
RA   Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., Rhodes K.J.;
RT   "Modulation of A-type potassium channels by a family of calcium sensors.";
RL   Nature 403:553-556(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), AND ALTERNATIVE SPLICING.
RX   PubMed=16112838; DOI=10.1016/j.ygeno.2005.07.001;
RA   Pruunsild P., Timmusk T.;
RT   "Structure, alternative splicing, and expression of the human and mouse
RT   KCNIP gene family.";
RL   Genomics 86:581-593(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Isbrandt D., Pongs O.;
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   INTERACTION WITH PSEN2, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND
RP   MUTAGENESIS OF ASP-61 AND ASP-64.
RX   PubMed=11278424; DOI=10.1074/jbc.m008597200;
RA   Choi E.K., Zaidi N.F., Miller J.S., Crowley A.C., Merriam D.E.,
RA   Lilliehook C., Buxbaum J.D., Wasco W.;
RT   "Calsenilin is a substrate for caspase-3 that preferentially interacts with
RT   the familial Alzheimer's disease-associated C-terminal fragment of
RT   presenilin 2.";
RL   J. Biol. Chem. 276:19197-19204(2001).
RN   [12]
RP   FUNCTION IN APOPTOSIS.
RX   PubMed=11259376; DOI=10.1096/fj.00-0541fje;
RA   Jo D.G., Kim M.J., Choi Y.H., Kim I.K., Song Y.H., Woo H.N., Chung C.W.,
RA   Jung Y.K.;
RT   "Pro-apoptotic function of calsenilin/DREAM/KChIP3.";
RL   FASEB J. 15:589-591(2001).
RN   [13]
RP   FUNCTION IN APOPTOSIS.
RX   PubMed=11988022; DOI=10.1006/mcne.2001.1096;
RA   Lilliehook C., Chan S., Choi E.K., Zaidi N.F., Wasco W., Mattson M.P.,
RA   Buxbaum J.D.;
RT   "Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium
RT   signaling.";
RL   Mol. Cell. Neurosci. 19:552-559(2002).
RN   [14]
RP   FUNCTION IN POTASSIUM TRANSPORT.
RX   PubMed=12829703; DOI=10.1074/jbc.m306142200;
RA   Shibata R., Misonou H., Campomanes C.R., Anderson A.E., Schrader L.A.,
RA   Doliveira L.C., Carroll K.I., Sweatt J.D., Rhodes K.J., Trimmer J.S.;
RT   "A fundamental role for KChIPs in determining the molecular properties and
RT   trafficking of Kv4.2 potassium channels.";
RL   J. Biol. Chem. 278:36445-36454(2003).
RN   [15]
RP   PHOSPHORYLATION AT SER-63.
RX   PubMed=12837631; DOI=10.1016/s1044-7431(03)00072-1;
RA   Choi E.K., Miller J.S., Zaidi N.F., Salih E., Buxbaum J.D., Wasco W.;
RT   "Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-
RT   3.";
RL   Mol. Cell. Neurosci. 23:495-506(2003).
RN   [16]
RP   INTERACTION WITH KCND2, FUNCTION IN POTASSIUM TRANSPORT, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15485870; DOI=10.1074/jbc.m409721200;
RA   Kunjilwar K., Strang C., DeRubeis D., Pfaffinger P.J.;
RT   "KChIP3 rescues the functional expression of Shal channel tetramerization
RT   mutants.";
RL   J. Biol. Chem. 279:54542-54551(2004).
RN   [17]
RP   TISSUE SPECIFICITY.
RX   PubMed=14720210; DOI=10.1111/j.1471-4159.2004.02159.x;
RA   Jo D.G., Lee J.Y., Hong Y.M., Song S., Mook-Jung I., Koh J.Y., Jung Y.K.;
RT   "Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease
RT   and cultured neurons after amyloid-beta exposure.";
RL   J. Neurochem. 88:604-611(2004).
RN   [18]
RP   FUNCTION IN POTASSIUM TRANSPORT.
RX   PubMed=16123112; DOI=10.1113/jphysiol.2005.087858;
RA   Jerng H.H., Kunjilwar K., Pfaffinger P.J.;
RT   "Multiprotein assembly of Kv4.2, KChIP3 and DPP10 produces ternary channel
RT   complexes with ISA-like properties.";
RL   J. Physiol. (Lond.) 568:767-788(2005).
RN   [19]
RP   FUNCTION IN POTASSIUM TRANSPORT, INTERACTION WITH KCND2, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18957440; DOI=10.1074/jbc.m806852200;
RA   Jerng H.H., Pfaffinger P.J.;
RT   "Multiple Kv channel-interacting proteins contain an N-terminal
RT   transmembrane domain that regulates Kv4 channel trafficking and gating.";
RL   J. Biol. Chem. 283:36046-36059(2008).
RN   [20]
RP   SUMOYLATION AT LYS-26 AND LYS-90, AND SUBCELLULAR LOCATION.
RX   PubMed=21070824; DOI=10.1016/j.bbamcr.2010.11.001;
RA   Palczewska M., Casafont I., Ghimire K., Rojas A.M., Valencia A.,
RA   Lafarga M., Mellstrom B., Naranjo J.R.;
RT   "Sumoylation regulates nuclear localization of repressor DREAM.";
RL   Biochim. Biophys. Acta 1813:1050-1058(2011).
RN   [21]
RP   STRUCTURE BY NMR OF 161-256, SUBUNIT, AND CALCIUM-BINDING.
RX   PubMed=17962406; DOI=10.1110/ps.072928007;
RA   Yu L., Sun C., Mendoza R., Wang J., Matayoshi E.D., Hebert E.,
RA   Pereda-Lopez A., Hajduk P.J., Olejniczak E.T.;
RT   "Solution structure and calcium-binding properties of EF-hands 3 and 4 of
RT   calsenilin.";
RL   Protein Sci. 16:2502-2509(2007).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-170 AND TYR-179.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Calcium-dependent transcriptional repressor that binds to the
CC       DRE element of genes including PDYN and FOS. Affinity for DNA is
CC       reduced upon binding to calcium and enhanced by binding to magnesium.
CC       Seems to be involved in nociception (By similarity).
CC       {ECO:0000250|UniProtKB:Q9QXT8}.
CC   -!- FUNCTION: Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly
CC       inactivating A-type potassium channels, such as KCND2/Kv4.2 and
CC       KCND3/Kv4.3. Modulates channel expression at the cell membrane, gating
CC       characteristics, inactivation kinetics and rate of recovery from
CC       inactivation in a calcium-dependent and isoform-specific manner.
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:12829703,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:18957440}.
CC   -!- FUNCTION: May play a role in the regulation of PSEN2 proteolytic
CC       processing and apoptosis. Together with PSEN2 involved in modulation of
CC       amyloid-beta formation. {ECO:0000269|PubMed:11259376,
CC       ECO:0000269|PubMed:11988022, ECO:0000269|PubMed:9771752}.
CC   -!- SUBUNIT: Binds to DNA as a homomultimer. Dimerization is induced by
CC       binding to calcium (PubMed:17962406). Interacts with the C-terminus of
CC       PSEN1 and PSEN2 and with PSEN2 CTF subunit. Associates with KCN1.
CC       Component of heteromultimeric potassium channels. Identified in
CC       potassium channel complexes containing KCND1, KCND2, KCND3, KCNIP1,
CC       KCNIP2, KCNIP3, KCNIP4, DPP6 and DPP10 (By similarity). Interacts with
CC       KCND2 and KCND3. {ECO:0000250|UniProtKB:Q9QXT8,
CC       ECO:0000269|PubMed:11278424, ECO:0000269|PubMed:15485870,
CC       ECO:0000269|PubMed:17962406, ECO:0000269|PubMed:18957440}.
CC   -!- INTERACTION:
CC       Q9Y2W7; P05067: APP; NbExp=3; IntAct=EBI-751501, EBI-77613;
CC       Q9Y2W7; Q12797-6: ASPH; NbExp=3; IntAct=EBI-751501, EBI-12092171;
CC       Q9Y2W7; Q9BXJ5: C1QTNF2; NbExp=3; IntAct=EBI-751501, EBI-2817707;
CC       Q9Y2W7; Q8N6Q3: CD177; NbExp=9; IntAct=EBI-751501, EBI-747170;
CC       Q9Y2W7; O14843: FFAR3; NbExp=3; IntAct=EBI-751501, EBI-17762181;
CC       Q9Y2W7; Q7Z5G4: GOLGA7; NbExp=3; IntAct=EBI-751501, EBI-4403685;
CC       Q9Y2W7; P08069: IGF1R; NbExp=6; IntAct=EBI-751501, EBI-475981;
CC       Q9Y2W7; P40189: IL6ST; NbExp=7; IntAct=EBI-751501, EBI-1030834;
CC       Q9Y2W7; Q17RA0: IL6ST; NbExp=3; IntAct=EBI-751501, EBI-10238517;
CC       Q9Y2W7; Q7Z7F0-4: KHDC4; NbExp=3; IntAct=EBI-751501, EBI-9089060;
CC       Q9Y2W7; P57682: KLF3; NbExp=3; IntAct=EBI-751501, EBI-8472267;
CC       Q9Y2W7; Q7Z434: MAVS; NbExp=3; IntAct=EBI-751501, EBI-995373;
CC       Q9Y2W7; Q8WZ73-3: RFFL; NbExp=3; IntAct=EBI-751501, EBI-25839575;
CC       Q9Y2W7; P08865: RPSA; NbExp=3; IntAct=EBI-751501, EBI-354112;
CC       Q9Y2W7; P08294: SOD3; NbExp=6; IntAct=EBI-751501, EBI-10195782;
CC       Q9Y2W7; Q86TD4-2: SRL; NbExp=3; IntAct=EBI-751501, EBI-12304565;
CC       Q9Y2W7; Q9BXU0: TEX12; NbExp=3; IntAct=EBI-751501, EBI-12090309;
CC       Q9Y2W7; Q8IUR5-4: TMTC1; NbExp=3; IntAct=EBI-751501, EBI-9089156;
CC       Q9Y2W7; O60844: ZG16; NbExp=3; IntAct=EBI-751501, EBI-746479;
CC       Q9Y2W7; A0A1U9X8X8; NbExp=3; IntAct=EBI-751501, EBI-17234977;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18957440}. Cell
CC       membrane {ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:18957440};
CC       Lipid-anchor {ECO:0000250}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:11278424, ECO:0000269|PubMed:18957440}. Golgi
CC       apparatus {ECO:0000269|PubMed:11278424}. Nucleus
CC       {ECO:0000269|PubMed:21070824}. Note=Also membrane-bound, associated
CC       with the plasma membrane (PubMed:15485870). In the presence of PSEN2
CC       associated with the endoplasmic reticulum and Golgi. The sumoylated
CC       form is present only in the nucleus. {ECO:0000269|PubMed:11278424,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:21070824}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=KChIP3.1;
CC         IsoId=Q9Y2W7-1; Sequence=Displayed;
CC       Name=2; Synonyms=KChIP3.2, KChIP4.2;
CC         IsoId=Q9Y2W7-2; Sequence=VSP_015040;
CC       Name=3; Synonyms=KChip3.x;
CC         IsoId=Q9Y2W7-3; Sequence=VSP_040982, VSP_040983;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain. Widely expressed at
CC       lower levels. Expression levels are elevated in brain cortex regions
CC       affected by Alzheimer disease. {ECO:0000269|PubMed:14720210}.
CC   -!- PTM: Palmitoylated. Palmitoylation enhances association with the plasma
CC       membrane (By similarity). {ECO:0000250}.
CC   -!- PTM: Proteolytically cleaved by caspase-3.
CC       {ECO:0000269|PubMed:11278424}.
CC   -!- PTM: Phosphorylation at Ser-63 inhibits cleavage by CASP3.
CC       {ECO:0000269|PubMed:11278424, ECO:0000269|PubMed:12837631}.
CC   -!- SIMILARITY: Belongs to the recoverin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF120102; AAD20350.1; -; mRNA.
DR   EMBL; AJ131730; CAB56836.1; -; mRNA.
DR   EMBL; AJ131730; CAB56835.1; -; mRNA.
DR   EMBL; AF199599; AAF33684.1; -; mRNA.
DR   EMBL; DQ148485; AAZ77802.1; -; mRNA.
DR   EMBL; DQ148486; AAZ77803.1; -; mRNA.
DR   EMBL; AF367022; AAK53711.1; -; mRNA.
DR   EMBL; BT020075; AAV38878.1; -; mRNA.
DR   EMBL; AK315437; BAG37825.1; -; mRNA.
DR   EMBL; AC009238; AAY14752.1; -; Genomic_DNA.
DR   EMBL; CH471219; EAX10724.1; -; Genomic_DNA.
DR   EMBL; BC012850; AAH12850.1; -; mRNA.
DR   CCDS; CCDS2013.1; -. [Q9Y2W7-1]
DR   CCDS; CCDS33245.1; -. [Q9Y2W7-3]
DR   RefSeq; NP_001030086.1; NM_001034914.1. [Q9Y2W7-3]
DR   RefSeq; NP_038462.1; NM_013434.4. [Q9Y2W7-1]
DR   PDB; 2E6W; NMR; -; A=161-256.
DR   PDBsum; 2E6W; -.
DR   AlphaFoldDB; Q9Y2W7; -.
DR   SMR; Q9Y2W7; -.
DR   BioGRID; 119042; 33.
DR   IntAct; Q9Y2W7; 24.
DR   STRING; 9606.ENSP00000295225; -.
DR   TCDB; 8.A.82.2.5; the calmodulin calcium binding protein (calmodulin) family.
DR   iPTMnet; Q9Y2W7; -.
DR   PhosphoSitePlus; Q9Y2W7; -.
DR   BioMuta; KCNIP3; -.
DR   DMDM; 13431428; -.
DR   MassIVE; Q9Y2W7; -.
DR   PaxDb; Q9Y2W7; -.
DR   PeptideAtlas; Q9Y2W7; -.
DR   PRIDE; Q9Y2W7; -.
DR   ProteomicsDB; 43500; -.
DR   ProteomicsDB; 85919; -. [Q9Y2W7-1]
DR   ProteomicsDB; 85920; -. [Q9Y2W7-2]
DR   ProteomicsDB; 85921; -. [Q9Y2W7-3]
DR   ABCD; Q9Y2W7; 2 sequenced antibodies.
DR   Antibodypedia; 4181; 546 antibodies from 41 providers.
DR   DNASU; 30818; -.
DR   Ensembl; ENST00000295225.10; ENSP00000295225.5; ENSG00000115041.13. [Q9Y2W7-1]
DR   Ensembl; ENST00000468529.1; ENSP00000417499.1; ENSG00000115041.13. [Q9Y2W7-3]
DR   GeneID; 30818; -.
DR   KEGG; hsa:30818; -.
DR   MANE-Select; ENST00000295225.10; ENSP00000295225.5; NM_013434.5; NP_038462.1.
DR   UCSC; uc002sup.4; human. [Q9Y2W7-1]
DR   CTD; 30818; -.
DR   DisGeNET; 30818; -.
DR   GeneCards; KCNIP3; -.
DR   HGNC; HGNC:15523; KCNIP3.
DR   HPA; ENSG00000115041; Low tissue specificity.
DR   MIM; 604662; gene.
DR   neXtProt; NX_Q9Y2W7; -.
DR   OpenTargets; ENSG00000115041; -.
DR   PharmGKB; PA26934; -.
DR   VEuPathDB; HostDB:ENSG00000115041; -.
DR   eggNOG; KOG0044; Eukaryota.
DR   GeneTree; ENSGT00940000158782; -.
DR   HOGENOM; CLU_072366_2_2_1; -.
DR   InParanoid; Q9Y2W7; -.
DR   OMA; NIFHPET; -.
DR   PhylomeDB; Q9Y2W7; -.
DR   TreeFam; TF318560; -.
DR   PathwayCommons; Q9Y2W7; -.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   SignaLink; Q9Y2W7; -.
DR   SIGNOR; Q9Y2W7; -.
DR   BioGRID-ORCS; 30818; 22 hits in 1077 CRISPR screens.
DR   ChiTaRS; KCNIP3; human.
DR   EvolutionaryTrace; Q9Y2W7; -.
DR   GeneWiki; Calsenilin; -.
DR   GenomeRNAi; 30818; -.
DR   Pharos; Q9Y2W7; Tbio.
DR   PRO; PR:Q9Y2W7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9Y2W7; protein.
DR   Bgee; ENSG00000115041; Expressed in right frontal lobe and 108 other tissues.
DR   ExpressionAtlas; Q9Y2W7; baseline and differential.
DR   Genevisible; Q9Y2W7; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; TAS:ProtInc.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:ARUK-UCL.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0015459; F:potassium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ARUK-UCL.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00051; EFh; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR028846; Recoverin.
DR   PANTHER; PTHR23055; PTHR23055; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 3.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Calcium; Cell membrane;
KW   Cytoplasm; Endoplasmic reticulum; Golgi apparatus; Ion channel;
KW   Ion transport; Isopeptide bond; Lipoprotein; Membrane; Metal-binding;
KW   Nucleus; Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN           1..256
FT                   /note="Calsenilin"
FT                   /id="PRO_0000073814"
FT   DOMAIN          67..123
FT                   /note="EF-hand 1; degenerate"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          126..161
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          162..197
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          210..245
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          243..256
FT                   /note="Interaction with KCND2"
FT                   /evidence="ECO:0000250"
FT   BINDING         175
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         177
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         179
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         181
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         186
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         223
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         225
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         227
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         234
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM47"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXT8"
FT   MOD_RES         63
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000269|PubMed:12837631"
FT   LIPID           45
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           46
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        26
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000269|PubMed:21070824"
FT   CROSSLNK        90
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000269|PubMed:21070824"
FT   VAR_SEQ         1..26
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16112838"
FT                   /id="VSP_040982"
FT   VAR_SEQ         27..60
FT                   /note="KEGIKWQRPRLSRQALMRCCLVKWILSSTAPQGS -> MGIQGMELCAMAVV
FT                   VLLFIAVLKQFGILEPISME (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16112838"
FT                   /id="VSP_040983"
FT   VAR_SEQ         103..124
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_015040"
FT   VARIANT         119
FT                   /note="A -> V (in dbSNP:rs35658670)"
FT                   /id="VAR_048663"
FT   VARIANT         170
FT                   /note="A -> S (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035463"
FT   VARIANT         179
FT                   /note="D -> Y (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035464"
FT   MUTAGEN         61
FT                   /note="D->A: Abolishes cleavage by caspase-3."
FT                   /evidence="ECO:0000269|PubMed:11278424"
FT   MUTAGEN         64
FT                   /note="D->A: Abolishes cleavage by caspase-3."
FT                   /evidence="ECO:0000269|PubMed:11278424"
FT   CONFLICT        182
FT                   /note="I -> V (in Ref. 2; CAB56836/CAB56835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="R -> Q (in Ref. 2; CAB56836/CAB56835)"
FT                   /evidence="ECO:0000305"
FT   HELIX           164..174
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   STRAND          179..182
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   HELIX           184..193
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   HELIX           214..222
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   STRAND          227..231
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   HELIX           232..239
FT                   /evidence="ECO:0007829|PDB:2E6W"
FT   HELIX           243..254
FT                   /evidence="ECO:0007829|PDB:2E6W"
SQ   SEQUENCE   256 AA;  29231 MW;  635C3EDF8B91E1C5 CRC64;
     MQPAKEVTKA SDGSLLGDLG HTPLSKKEGI KWQRPRLSRQ ALMRCCLVKW ILSSTAPQGS
     DSSDSELELS TVRHQPEGLD QLQAQTKFTK KELQSLYRGF KNECPTGLVD EDTFKLIYAQ
     FFPQGDATTY AHFLFNAFDA DGNGAIHFED FVVGLSILLR GTVHEKLKWA FNLYDINKDG
     YITKEEMLAI MKSIYDMMGR HTYPILREDA PAEHVERFFE KMDRNQDGVV TIEEFLEACQ
     KDENIMSSMQ LFENVI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024